Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoplastic Left Heart Syndrome | 22 | 2024 | 594 | 1.980 |
Why?
|
Shock, Cardiogenic | 40 | 2011 | 734 | 1.900 |
Why?
|
Heart Defects, Congenital | 39 | 2024 | 4673 | 1.740 |
Why?
|
Norwood Procedures | 15 | 2019 | 192 | 1.500 |
Why?
|
Fontan Procedure | 19 | 2023 | 791 | 1.490 |
Why?
|
Tetralogy of Fallot | 11 | 2024 | 631 | 1.440 |
Why?
|
Cardiomyopathy, Dilated | 17 | 2017 | 819 | 1.420 |
Why?
|
Heart Ventricles | 33 | 2023 | 3811 | 1.410 |
Why?
|
Pulmonary Valve | 8 | 2023 | 414 | 1.060 |
Why?
|
Blalock-Taussig Procedure | 9 | 2019 | 60 | 1.060 |
Why?
|
Myocardial Revascularization | 29 | 2011 | 841 | 1.050 |
Why?
|
Cardiac Surgical Procedures | 22 | 2024 | 3620 | 1.050 |
Why?
|
Marfan Syndrome | 8 | 2022 | 236 | 1.030 |
Why?
|
Registries | 51 | 2024 | 8469 | 0.910 |
Why?
|
Aortic Valve Insufficiency | 5 | 2021 | 584 | 0.840 |
Why?
|
Heart Transplantation | 25 | 2023 | 3224 | 0.820 |
Why?
|
Infant | 101 | 2024 | 36060 | 0.770 |
Why?
|
Ventricular Function, Left | 21 | 2024 | 3880 | 0.770 |
Why?
|
Mitral Valve Insufficiency | 9 | 2024 | 1419 | 0.750 |
Why?
|
Echocardiography | 30 | 2023 | 4981 | 0.750 |
Why?
|
Ventricular Dysfunction, Left | 20 | 2021 | 2128 | 0.720 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2021 | 355 | 0.690 |
Why?
|
Atenolol | 6 | 2020 | 99 | 0.690 |
Why?
|
Cardiomyopathy, Hypertrophic | 8 | 2018 | 1311 | 0.670 |
Why?
|
Child, Preschool | 95 | 2024 | 42063 | 0.610 |
Why?
|
Losartan | 6 | 2020 | 265 | 0.610 |
Why?
|
Child | 117 | 2024 | 79806 | 0.600 |
Why?
|
Sudden Infant Death | 8 | 2024 | 291 | 0.580 |
Why?
|
Heart Diseases | 9 | 2024 | 2809 | 0.570 |
Why?
|
Hypertension, Pulmonary | 3 | 2022 | 1570 | 0.560 |
Why?
|
Heart Valve Diseases | 2 | 2020 | 1047 | 0.520 |
Why?
|
Pulmonary Artery | 10 | 2022 | 1921 | 0.510 |
Why?
|
Angioplasty, Balloon, Coronary | 17 | 2012 | 1880 | 0.510 |
Why?
|
Heart Valve Prosthesis Implantation | 7 | 2023 | 1582 | 0.500 |
Why?
|
Pulmonary Valve Insufficiency | 3 | 2023 | 143 | 0.490 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 5 | 2011 | 537 | 0.490 |
Why?
|
Palliative Care | 11 | 2024 | 3607 | 0.460 |
Why?
|
Ventricular Dysfunction, Right | 5 | 2021 | 615 | 0.450 |
Why?
|
Coronary Artery Bypass | 17 | 2014 | 2272 | 0.450 |
Why?
|
Fetal Diseases | 4 | 2022 | 911 | 0.450 |
Why?
|
Infant, Newborn | 55 | 2024 | 26181 | 0.450 |
Why?
|
Aortic Valve Stenosis | 7 | 2022 | 2065 | 0.440 |
Why?
|
Myocardial Infarction | 39 | 2012 | 11891 | 0.430 |
Why?
|
Retrospective Studies | 75 | 2024 | 80372 | 0.420 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 1459 | 0.410 |
Why?
|
Stroke Volume | 19 | 2022 | 5523 | 0.400 |
Why?
|
Heart Septal Defects, Ventricular | 4 | 2022 | 491 | 0.380 |
Why?
|
Treatment Outcome | 72 | 2024 | 65017 | 0.380 |
Why?
|
Intra-Aortic Balloon Pumping | 13 | 2011 | 227 | 0.360 |
Why?
|
Humans | 253 | 2024 | 760621 | 0.360 |
Why?
|
Peptic Ulcer | 2 | 2024 | 219 | 0.360 |
Why?
|
Male | 177 | 2024 | 359744 | 0.360 |
Why?
|
Postoperative Hemorrhage | 3 | 2019 | 422 | 0.360 |
Why?
|
Female | 181 | 2024 | 391270 | 0.360 |
Why?
|
Partial Thromboplastin Time | 3 | 2021 | 205 | 0.360 |
Why?
|
Hemodynamics | 13 | 2023 | 4174 | 0.360 |
Why?
|
Postoperative Complications | 22 | 2021 | 15697 | 0.350 |
Why?
|
Ventricular Remodeling | 6 | 2023 | 1261 | 0.340 |
Why?
|
Quality of Life | 9 | 2023 | 13308 | 0.340 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 5 | 2020 | 435 | 0.340 |
Why?
|
Adolescent | 73 | 2024 | 87810 | 0.330 |
Why?
|
Ventricular Function | 7 | 2012 | 408 | 0.320 |
Why?
|
Hospital Mortality | 21 | 2018 | 5425 | 0.320 |
Why?
|
Social Class | 5 | 2023 | 2005 | 0.320 |
Why?
|
Blood Coagulation | 3 | 2019 | 1157 | 0.300 |
Why?
|
Thrombolytic Therapy | 17 | 2010 | 2108 | 0.300 |
Why?
|
Heart Neoplasms | 2 | 2021 | 360 | 0.290 |
Why?
|
Thrombelastography | 2 | 2021 | 183 | 0.290 |
Why?
|
Aortic Diseases | 3 | 2020 | 736 | 0.290 |
Why?
|
Heart Septal Defects | 2 | 2023 | 191 | 0.290 |
Why?
|
Exercise Tolerance | 3 | 2019 | 830 | 0.280 |
Why?
|
Heparin | 3 | 2019 | 1652 | 0.280 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2010 | 664 | 0.280 |
Why?
|
Bioprosthesis | 3 | 2021 | 600 | 0.270 |
Why?
|
Time Factors | 42 | 2024 | 40165 | 0.270 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2022 | 1259 | 0.270 |
Why?
|
Developmental Disabilities | 6 | 2020 | 1504 | 0.260 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 3 | 2020 | 30 | 0.260 |
Why?
|
Predictive Value of Tests | 15 | 2024 | 15289 | 0.260 |
Why?
|
Serotonin | 4 | 2024 | 1040 | 0.260 |
Why?
|
Age Factors | 26 | 2020 | 18416 | 0.260 |
Why?
|
Length of Stay | 16 | 2022 | 6479 | 0.260 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2005 | 82 | 0.250 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2018 | 461 | 0.250 |
Why?
|
Reoperation | 10 | 2023 | 4291 | 0.250 |
Why?
|
Troponin | 2 | 2020 | 516 | 0.250 |
Why?
|
Magnetic Resonance Imaging, Cine | 6 | 2021 | 1046 | 0.240 |
Why?
|
Kaplan-Meier Estimate | 15 | 2020 | 6544 | 0.240 |
Why?
|
Drug Resistance | 1 | 2010 | 1617 | 0.240 |
Why?
|
Nervous System | 2 | 2020 | 543 | 0.230 |
Why?
|
Leukomalacia, Periventricular | 3 | 2013 | 184 | 0.230 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15840 | 0.230 |
Why?
|
Follow-Up Studies | 35 | 2022 | 39261 | 0.230 |
Why?
|
Enalapril | 3 | 2011 | 313 | 0.230 |
Why?
|
Ventricular Dysfunction | 2 | 2018 | 145 | 0.220 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2024 | 144 | 0.220 |
Why?
|
Survival Rate | 22 | 2021 | 12808 | 0.220 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 6 | 2022 | 1523 | 0.220 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1303 | 0.220 |
Why?
|
Heart Valve Prosthesis | 4 | 2021 | 1495 | 0.220 |
Why?
|
14-3-3 Proteins | 1 | 2024 | 221 | 0.210 |
Why?
|
Prospective Studies | 54 | 2024 | 54303 | 0.210 |
Why?
|
Risk Factors | 50 | 2024 | 74359 | 0.210 |
Why?
|
Risk Assessment | 26 | 2024 | 24123 | 0.210 |
Why?
|
Mitral Valve | 2 | 2024 | 1486 | 0.210 |
Why?
|
Endocardial Fibroelastosis | 1 | 2023 | 56 | 0.210 |
Why?
|
Educational Status | 3 | 2020 | 2515 | 0.210 |
Why?
|
Drug-Eluting Stents | 4 | 2012 | 757 | 0.210 |
Why?
|
Cost of Illness | 2 | 2023 | 1940 | 0.200 |
Why?
|
Proportional Hazards Models | 20 | 2020 | 12531 | 0.200 |
Why?
|
Heart-Assist Devices | 3 | 2024 | 1291 | 0.200 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2018 | 613 | 0.200 |
Why?
|
Cardiopulmonary Bypass | 2 | 2018 | 1096 | 0.200 |
Why?
|
Immunologic Factors | 2 | 2010 | 1588 | 0.200 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2022 | 273 | 0.200 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2005 | 352 | 0.200 |
Why?
|
Anemia, Sickle Cell | 10 | 2001 | 1056 | 0.190 |
Why?
|
Thrombosis | 4 | 2019 | 3052 | 0.190 |
Why?
|
Fathers | 1 | 2024 | 376 | 0.180 |
Why?
|
Heart Failure | 13 | 2024 | 11847 | 0.180 |
Why?
|
Pulmonary Circulation | 3 | 2020 | 743 | 0.180 |
Why?
|
Prognosis | 25 | 2024 | 29658 | 0.180 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 51 | 0.180 |
Why?
|
Cardiomyopathies | 4 | 2021 | 1952 | 0.180 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
Factor Xa | 2 | 2018 | 168 | 0.180 |
Why?
|
Parents | 4 | 2023 | 3549 | 0.180 |
Why?
|
Ebstein Anomaly | 1 | 2021 | 101 | 0.180 |
Why?
|
Encephalitis | 1 | 2024 | 437 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2255 | 0.170 |
Why?
|
Blood Circulation | 1 | 2021 | 249 | 0.170 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2020 | 51 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Anti-Ulcer Agents | 1 | 2020 | 113 | 0.170 |
Why?
|
Down Syndrome | 2 | 2022 | 892 | 0.170 |
Why?
|
Recovery of Function | 6 | 2018 | 2985 | 0.170 |
Why?
|
Fibroma | 1 | 2021 | 190 | 0.170 |
Why?
|
Coronary Angiography | 16 | 2009 | 4563 | 0.170 |
Why?
|
Young Adult | 25 | 2024 | 58741 | 0.160 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 167 | 0.160 |
Why?
|
North America | 8 | 2016 | 1284 | 0.160 |
Why?
|
Ventricular Function, Right | 5 | 2023 | 610 | 0.160 |
Why?
|
Multivariate Analysis | 14 | 2017 | 12159 | 0.160 |
Why?
|
Heart Valves | 1 | 2020 | 285 | 0.160 |
Why?
|
Anticoagulants | 3 | 2019 | 4897 | 0.160 |
Why?
|
Diastole | 2 | 2022 | 788 | 0.150 |
Why?
|
Protamines | 1 | 2018 | 112 | 0.150 |
Why?
|
Systole | 2 | 2021 | 947 | 0.150 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 25942 | 0.150 |
Why?
|
Reference Values | 7 | 2023 | 4925 | 0.150 |
Why?
|
Vasodilator Agents | 1 | 2022 | 978 | 0.150 |
Why?
|
Transposition of Great Vessels | 1 | 2022 | 590 | 0.150 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2017 | 322 | 0.150 |
Why?
|
Diabetes Complications | 4 | 2012 | 1341 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2022 | 10344 | 0.150 |
Why?
|
Coronary Artery Disease | 7 | 2012 | 6659 | 0.150 |
Why?
|
Diabetic Angiopathies | 2 | 2012 | 822 | 0.140 |
Why?
|
Fetus | 2 | 2022 | 1859 | 0.140 |
Why?
|
Death, Sudden, Cardiac | 2 | 2018 | 1572 | 0.140 |
Why?
|
Reproducibility of Results | 15 | 2024 | 20080 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1131 | 0.140 |
Why?
|
Medulla Oblongata | 3 | 2005 | 248 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2021 | 495 | 0.140 |
Why?
|
Fetal Heart | 1 | 2018 | 281 | 0.140 |
Why?
|
Echocardiography, Doppler | 4 | 2014 | 901 | 0.140 |
Why?
|
Critical Illness | 4 | 2024 | 2709 | 0.140 |
Why?
|
Cohort Studies | 18 | 2022 | 41335 | 0.140 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1516 | 0.130 |
Why?
|
Aortic Valve | 3 | 2021 | 1996 | 0.130 |
Why?
|
United States | 32 | 2024 | 72461 | 0.130 |
Why?
|
Child Development | 4 | 2020 | 2285 | 0.130 |
Why?
|
Hypoxia, Brain | 2 | 2013 | 138 | 0.130 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3865 | 0.130 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 22 | 0.130 |
Why?
|
Mothers | 6 | 2023 | 2186 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 725 | 0.130 |
Why?
|
Brain Stem | 6 | 2024 | 857 | 0.120 |
Why?
|
Survival Analysis | 14 | 2018 | 10182 | 0.120 |
Why?
|
Clinical Trials as Topic | 5 | 2013 | 8056 | 0.120 |
Why?
|
Drug Monitoring | 2 | 2018 | 965 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2018 | 537 | 0.120 |
Why?
|
Gastroesophageal Reflux | 1 | 2022 | 816 | 0.120 |
Why?
|
Adult | 48 | 2024 | 219994 | 0.120 |
Why?
|
Aorta | 3 | 2022 | 2039 | 0.120 |
Why?
|
Electric Countershock | 1 | 2018 | 537 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2024 | 5201 | 0.120 |
Why?
|
Coronary Vessels | 3 | 2011 | 3112 | 0.120 |
Why?
|
Dilatation, Pathologic | 4 | 2020 | 527 | 0.120 |
Why?
|
Heart Block | 1 | 2016 | 392 | 0.120 |
Why?
|
Coronary Circulation | 3 | 2018 | 1577 | 0.120 |
Why?
|
Sarcomeres | 1 | 2017 | 367 | 0.120 |
Why?
|
Emergency Treatment | 4 | 2005 | 498 | 0.110 |
Why?
|
Nerve Block | 1 | 2020 | 688 | 0.110 |
Why?
|
Logistic Models | 11 | 2021 | 13314 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 944 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 1031 | 0.110 |
Why?
|
Blood Platelets | 1 | 2024 | 2520 | 0.110 |
Why?
|
Myocarditis | 3 | 2011 | 766 | 0.110 |
Why?
|
Canada | 7 | 2017 | 2128 | 0.110 |
Why?
|
Health Status | 6 | 2018 | 4081 | 0.110 |
Why?
|
Heart Bypass, Right | 2 | 2010 | 75 | 0.110 |
Why?
|
Infant, Premature, Diseases | 2 | 2013 | 708 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2018 | 1717 | 0.100 |
Why?
|
Hospitals, Pediatric | 4 | 2018 | 1854 | 0.100 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2012 | 62 | 0.100 |
Why?
|
Incidence | 18 | 2017 | 21392 | 0.100 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 741 | 0.100 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2011 | 69 | 0.100 |
Why?
|
Thoracic Arteries | 1 | 2011 | 40 | 0.100 |
Why?
|
Residence Characteristics | 2 | 2020 | 2062 | 0.100 |
Why?
|
Noonan Syndrome | 1 | 2012 | 120 | 0.100 |
Why?
|
Exercise Test | 7 | 2018 | 2128 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2013 | 0.100 |
Why?
|
Waiting Lists | 2 | 2022 | 763 | 0.100 |
Why?
|
Hemorrhage | 2 | 2021 | 3600 | 0.100 |
Why?
|
Psychomotor Disorders | 1 | 2012 | 149 | 0.090 |
Why?
|
Contrast Media | 2 | 2021 | 5305 | 0.090 |
Why?
|
Income | 2 | 2020 | 1875 | 0.090 |
Why?
|
Cause of Death | 6 | 2024 | 3725 | 0.090 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 71 | 0.090 |
Why?
|
Child, Hospitalized | 2 | 2024 | 182 | 0.090 |
Why?
|
Quality Improvement | 2 | 2024 | 3836 | 0.090 |
Why?
|
Vascular Grafting | 1 | 2012 | 154 | 0.090 |
Why?
|
Afghan Campaign 2001- | 1 | 2011 | 296 | 0.090 |
Why?
|
Longitudinal Studies | 11 | 2023 | 14495 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2011 | 169 | 0.090 |
Why?
|
Middle Aged | 47 | 2024 | 220352 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1376 | 0.090 |
Why?
|
Aortic Aneurysm | 1 | 2014 | 648 | 0.090 |
Why?
|
Combat Disorders | 1 | 2011 | 301 | 0.080 |
Why?
|
Cardiology | 2 | 2018 | 1723 | 0.080 |
Why?
|
Temporal Lobe | 1 | 2017 | 1688 | 0.080 |
Why?
|
Aged | 49 | 2021 | 169152 | 0.080 |
Why?
|
Physicians | 2 | 2018 | 4591 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1941 | 0.080 |
Why?
|
Double-Blind Method | 6 | 2020 | 12427 | 0.080 |
Why?
|
Patient Selection | 8 | 2020 | 4283 | 0.080 |
Why?
|
Health Resources | 1 | 2015 | 935 | 0.080 |
Why?
|
Pregnancy | 11 | 2022 | 29749 | 0.080 |
Why?
|
Hemophilia A | 4 | 1997 | 359 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17790 | 0.080 |
Why?
|
Disease-Free Survival | 6 | 2018 | 6828 | 0.080 |
Why?
|
Clinical Competence | 2 | 2017 | 4783 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2290 | 0.080 |
Why?
|
Gestational Age | 6 | 2021 | 3565 | 0.080 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2234 | 0.080 |
Why?
|
Heart Rate | 5 | 2021 | 4179 | 0.080 |
Why?
|
Electrocardiography | 7 | 2017 | 6414 | 0.080 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1499 | 0.080 |
Why?
|
Phenotype | 6 | 2020 | 16546 | 0.080 |
Why?
|
ROC Curve | 3 | 2013 | 3568 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3531 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4215 | 0.070 |
Why?
|
Hospitalization | 4 | 2024 | 10790 | 0.070 |
Why?
|
Situs Inversus | 1 | 2007 | 63 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 3 | 2022 | 1745 | 0.070 |
Why?
|
Databases, Factual | 6 | 2021 | 8035 | 0.070 |
Why?
|
Preoperative Care | 2 | 2018 | 2256 | 0.070 |
Why?
|
Multicenter Studies as Topic | 3 | 2006 | 1722 | 0.070 |
Why?
|
Oxygen Consumption | 4 | 2019 | 1843 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 738 | 0.070 |
Why?
|
Chemical Warfare | 1 | 1986 | 18 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2020 | 2852 | 0.070 |
Why?
|
Gadolinium | 2 | 2021 | 959 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 952 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2014 | 3465 | 0.060 |
Why?
|
Terminal Care | 1 | 2018 | 1758 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2024 | 2135 | 0.060 |
Why?
|
Protective Clothing | 1 | 1986 | 103 | 0.060 |
Why?
|
Intraoperative Complications | 2 | 1995 | 1186 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4193 | 0.060 |
Why?
|
beta-Thalassemia | 4 | 2000 | 235 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2007 | 384 | 0.060 |
Why?
|
Receptors, Serotonin | 3 | 2003 | 208 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2018 | 5125 | 0.060 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2008 | 268 | 0.060 |
Why?
|
Gram-Negative Bacteria | 1 | 2007 | 272 | 0.060 |
Why?
|
Puberty, Delayed | 2 | 1997 | 121 | 0.060 |
Why?
|
Research Design | 6 | 2015 | 6180 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 12 | 2021 | 36290 | 0.060 |
Why?
|
Odds Ratio | 6 | 2020 | 9716 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3340 | 0.060 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 368 | 0.060 |
Why?
|
Career Choice | 1 | 2011 | 754 | 0.060 |
Why?
|
Neopterin | 1 | 2024 | 56 | 0.060 |
Why?
|
Abnormalities, Multiple | 2 | 2012 | 1415 | 0.060 |
Why?
|
Pilot Projects | 3 | 2024 | 8555 | 0.060 |
Why?
|
Risk Management | 1 | 2007 | 558 | 0.060 |
Why?
|
Pediatrics | 3 | 2015 | 3586 | 0.060 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2011 | 698 | 0.060 |
Why?
|
Growth Disorders | 3 | 2011 | 653 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1758 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2021 | 1014 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1824 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2001 | 0.060 |
Why?
|
Disease Progression | 7 | 2021 | 13502 | 0.060 |
Why?
|
Perceptual Disorders | 1 | 1986 | 197 | 0.060 |
Why?
|
Miniaturization | 1 | 2024 | 153 | 0.060 |
Why?
|
Brain | 5 | 2017 | 26951 | 0.060 |
Why?
|
Intensive Care Units | 4 | 2022 | 3736 | 0.050 |
Why?
|
Thoracic Duct | 1 | 2023 | 64 | 0.050 |
Why?
|
Cerebral Ventricles | 2 | 2005 | 542 | 0.050 |
Why?
|
Propensity Score | 2 | 2023 | 1928 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 820 | 0.050 |
Why?
|
Cataract Extraction | 1 | 1987 | 465 | 0.050 |
Why?
|
Emergency Medical Services | 2 | 2005 | 1925 | 0.050 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2011 | 354 | 0.050 |
Why?
|
Ulcer | 1 | 2024 | 204 | 0.050 |
Why?
|
Algorithms | 4 | 2022 | 13981 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.050 |
Why?
|
Morphine Derivatives | 1 | 2021 | 42 | 0.050 |
Why?
|
Autoradiography | 5 | 2003 | 730 | 0.050 |
Why?
|
Autopsy | 2 | 2017 | 1007 | 0.050 |
Why?
|
Morbidity | 2 | 2021 | 1765 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2011 | 1413 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2011 | 2145 | 0.050 |
Why?
|
Respiratory Center | 1 | 2001 | 18 | 0.050 |
Why?
|
Bacteremia | 2 | 2007 | 980 | 0.050 |
Why?
|
Case-Control Studies | 7 | 2024 | 22053 | 0.050 |
Why?
|
Heart Atria | 1 | 2007 | 1346 | 0.050 |
Why?
|
Coitus | 2 | 2007 | 131 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2015 | 681 | 0.050 |
Why?
|
Boston | 3 | 2018 | 9280 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2001 | 69 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 343 | 0.050 |
Why?
|
Ventricular Septal Rupture | 1 | 2000 | 17 | 0.050 |
Why?
|
Cerebral Palsy | 1 | 2005 | 471 | 0.050 |
Why?
|
Interviews as Topic | 3 | 2018 | 2659 | 0.040 |
Why?
|
Linear Models | 3 | 2018 | 5877 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5397 | 0.040 |
Why?
|
Graft Survival | 2 | 2023 | 3794 | 0.040 |
Why?
|
alpha-Thalassemia | 3 | 1998 | 52 | 0.040 |
Why?
|
Cardiotonic Agents | 3 | 2010 | 546 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2005 | 621 | 0.040 |
Why?
|
Data Collection | 3 | 2013 | 3315 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4899 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6597 | 0.040 |
Why?
|
Quinuclidinyl Benzilate | 2 | 1998 | 19 | 0.040 |
Why?
|
Neurons | 2 | 2012 | 9426 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1098 | 0.040 |
Why?
|
Patient Discharge | 2 | 2024 | 3476 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2012 | 4360 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 315 | 0.040 |
Why?
|
Fibrinolytic Agents | 3 | 2012 | 2167 | 0.040 |
Why?
|
Hot Temperature | 1 | 1986 | 1435 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 733 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2020 | 362 | 0.040 |
Why?
|
Receptors, Muscarinic | 2 | 1998 | 157 | 0.040 |
Why?
|
Image Enhancement | 3 | 2012 | 2881 | 0.040 |
Why?
|
Observer Variation | 3 | 2020 | 2601 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1462 | 0.040 |
Why?
|
Hemoglobin C Disease | 2 | 1995 | 8 | 0.040 |
Why?
|
Genotype | 5 | 2020 | 12960 | 0.040 |
Why?
|
Receptors, Nicotinic | 2 | 1998 | 494 | 0.040 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 265 | 0.040 |
Why?
|
Australia | 2 | 2018 | 1289 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2021 | 409 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 515 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2007 | 2086 | 0.040 |
Why?
|
Sex Distribution | 3 | 2014 | 2295 | 0.040 |
Why?
|
Policy | 1 | 2022 | 511 | 0.040 |
Why?
|
Receptors, Kainic Acid | 1 | 1997 | 90 | 0.040 |
Why?
|
Receptors, Neurotransmitter | 1 | 1998 | 174 | 0.040 |
Why?
|
Blood Pressure | 4 | 2007 | 8525 | 0.040 |
Why?
|
Patient Readmission | 2 | 2024 | 3323 | 0.040 |
Why?
|
Veterans | 1 | 2011 | 2642 | 0.040 |
Why?
|
Visual Perception | 1 | 1986 | 1374 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 1997 | 26 | 0.040 |
Why?
|
Spinal Cord | 1 | 2005 | 1817 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2018 | 245 | 0.040 |
Why?
|
Prevalence | 6 | 2015 | 15687 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 5889 | 0.040 |
Why?
|
Infant Mortality | 2 | 2012 | 757 | 0.040 |
Why?
|
Up-Regulation | 2 | 2020 | 4122 | 0.040 |
Why?
|
Pericardium | 1 | 2021 | 675 | 0.040 |
Why?
|
Lysergic Acid Diethylamide | 3 | 2003 | 47 | 0.030 |
Why?
|
Fetal Therapies | 1 | 2018 | 101 | 0.030 |
Why?
|
Brain Damage, Chronic | 2 | 2012 | 267 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6498 | 0.030 |
Why?
|
Military Personnel | 1 | 1986 | 1244 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2016 | 1377 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2017 | 212 | 0.030 |
Why?
|
Patient Transfer | 1 | 2003 | 779 | 0.030 |
Why?
|
Causality | 2 | 2016 | 1242 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 600 | 0.030 |
Why?
|
Jugular Veins | 1 | 2017 | 211 | 0.030 |
Why?
|
Mesencephalon | 1 | 1998 | 332 | 0.030 |
Why?
|
Aldosterone | 2 | 2011 | 868 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1257 | 0.030 |
Why?
|
Cattle | 1 | 2021 | 3847 | 0.030 |
Why?
|
Amniotic Fluid | 1 | 2018 | 378 | 0.030 |
Why?
|
Pregnancy Outcome | 2 | 2018 | 2907 | 0.030 |
Why?
|
Neuropsychological Tests | 3 | 2014 | 7021 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2012 | 5761 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2018 | 578 | 0.030 |
Why?
|
Cervix Mucus | 1 | 1995 | 17 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
Comorbidity | 5 | 2012 | 10551 | 0.030 |
Why?
|
Platelet Transfusion | 1 | 2018 | 294 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1264 | 0.030 |
Why?
|
Malformations of Cortical Development | 1 | 2017 | 177 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3426 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2010 | 784 | 0.030 |
Why?
|
Prenatal Care | 1 | 2022 | 1129 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 1997 | 955 | 0.030 |
Why?
|
Diuretics | 2 | 2010 | 613 | 0.030 |
Why?
|
Exercise | 2 | 2008 | 5787 | 0.030 |
Why?
|
Survivors | 2 | 2020 | 2375 | 0.030 |
Why?
|
Body Height | 3 | 2014 | 1570 | 0.030 |
Why?
|
Health Education | 1 | 2021 | 1049 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1998 | 445 | 0.030 |
Why?
|
Stroke | 5 | 2012 | 9962 | 0.030 |
Why?
|
Oximetry | 1 | 2017 | 461 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 1999 | 982 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2011 | 4555 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2893 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2000 | 978 | 0.030 |
Why?
|
Hemoglobin SC Disease | 1 | 1993 | 23 | 0.030 |
Why?
|
Cerebrovascular Disorders | 2 | 1998 | 1501 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2013 | 6238 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8950 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2116 | 0.030 |
Why?
|
Coronary Disease | 1 | 2008 | 5990 | 0.030 |
Why?
|
Australasia | 1 | 2012 | 21 | 0.030 |
Why?
|
Infant, Premature | 2 | 2013 | 2092 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3765 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2648 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 1998 | 487 | 0.030 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1994 | 177 | 0.030 |
Why?
|
Urban Health | 1 | 1995 | 533 | 0.030 |
Why?
|
South America | 1 | 2012 | 181 | 0.030 |
Why?
|
Achievement | 1 | 1994 | 289 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 29932 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2313 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 1997 | 638 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
Poverty | 1 | 2023 | 2695 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12965 | 0.020 |
Why?
|
Emergencies | 3 | 2006 | 1211 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2017 | 854 | 0.020 |
Why?
|
Stents | 1 | 2003 | 3314 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2018 | 1328 | 0.020 |
Why?
|
Metabolism, Inborn Errors | 1 | 2013 | 285 | 0.020 |
Why?
|
Humerus | 1 | 1993 | 269 | 0.020 |
Why?
|
Osteonecrosis | 1 | 1993 | 229 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2001 | 2629 | 0.020 |
Why?
|
Child Abuse, Sexual | 1 | 1994 | 392 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1434 | 0.020 |
Why?
|
Femur Head Necrosis | 1 | 1991 | 132 | 0.020 |
Why?
|
Infertility, Female | 1 | 1997 | 759 | 0.020 |
Why?
|
Spermatozoa | 1 | 1995 | 631 | 0.020 |
Why?
|
Angiotensins | 1 | 2011 | 143 | 0.020 |
Why?
|
Th1 Cells | 1 | 1995 | 1032 | 0.020 |
Why?
|
Postoperative Care | 1 | 2017 | 1479 | 0.020 |
Why?
|
Chronic Disease | 2 | 2023 | 9287 | 0.020 |
Why?
|
Respiration, Artificial | 2 | 2015 | 2622 | 0.020 |
Why?
|
Th2 Cells | 1 | 1995 | 1047 | 0.020 |
Why?
|
Critical Care | 2 | 2015 | 2699 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2012 | 12293 | 0.020 |
Why?
|
Homes for the Aged | 1 | 1992 | 272 | 0.020 |
Why?
|
Survival | 1 | 2010 | 161 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1721 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2011 | 292 | 0.020 |
Why?
|
Glycosides | 1 | 2010 | 111 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4166 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1407 | 0.020 |
Why?
|
Home Care Services | 1 | 1996 | 654 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 361 | 0.020 |
Why?
|
Radioligand Assay | 2 | 2001 | 366 | 0.020 |
Why?
|
Exercise Therapy | 1 | 1996 | 919 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2009 | 199 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1994 | 592 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 14660 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1407 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 1994 | 805 | 0.020 |
Why?
|
Renin | 1 | 2011 | 635 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 422 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7343 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2916 | 0.020 |
Why?
|
Catheterization | 2 | 2007 | 1432 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2131 | 0.020 |
Why?
|
Confidentiality | 1 | 2013 | 609 | 0.020 |
Why?
|
Gene Dosage | 1 | 2013 | 1218 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2018 | 1446 | 0.020 |
Why?
|
Child Behavior | 1 | 1994 | 847 | 0.020 |
Why?
|
Infertility | 1 | 1995 | 655 | 0.020 |
Why?
|
Orgasm | 1 | 2007 | 61 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1835 | 0.020 |
Why?
|
Kainic Acid | 2 | 1998 | 199 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 1097 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2007 | 36 | 0.020 |
Why?
|
Lens Capsule, Crystalline | 1 | 1987 | 39 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2013 | 783 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2254 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 934 | 0.020 |
Why?
|
Syndrome | 2 | 2007 | 3280 | 0.020 |
Why?
|
Mandatory Reporting | 1 | 2007 | 124 | 0.020 |
Why?
|
Hospital Costs | 1 | 2012 | 976 | 0.020 |
Why?
|
Gas Poisoning | 1 | 1986 | 5 | 0.020 |
Why?
|
Models, Statistical | 2 | 2005 | 5075 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7233 | 0.020 |
Why?
|
Pupil | 1 | 1987 | 141 | 0.020 |
Why?
|
Schools, Medical | 1 | 2013 | 878 | 0.020 |
Why?
|
Software | 1 | 2020 | 4419 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1724 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1878 | 0.020 |
Why?
|
HIV Seronegativity | 2 | 1997 | 208 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2475 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3441 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10827 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 805 | 0.020 |
Why?
|
New York | 1 | 2007 | 875 | 0.020 |
Why?
|
Aged, 80 and over | 7 | 2007 | 58995 | 0.020 |
Why?
|
Vitreous Body | 1 | 1987 | 399 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2917 | 0.020 |
Why?
|
Klebsiella pneumoniae | 1 | 2007 | 255 | 0.020 |
Why?
|
Nursing Homes | 1 | 1992 | 1082 | 0.020 |
Why?
|
Anesthesia | 1 | 1995 | 1584 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1037 | 0.010 |
Why?
|
Regression Analysis | 2 | 2010 | 6360 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4107 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3763 | 0.010 |
Why?
|
Acute Disease | 2 | 2011 | 7269 | 0.010 |
Why?
|
Postoperative Period | 1 | 2009 | 1818 | 0.010 |
Why?
|
Muscle Hypotonia | 1 | 2005 | 160 | 0.010 |
Why?
|
Hypotension | 2 | 2000 | 883 | 0.010 |
Why?
|
Counterpulsation | 1 | 2003 | 18 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1995 | 1913 | 0.010 |
Why?
|
HIV Infections | 3 | 1995 | 17165 | 0.010 |
Why?
|
Single-Blind Method | 2 | 2000 | 1578 | 0.010 |
Why?
|
Weight Gain | 1 | 2014 | 2347 | 0.010 |
Why?
|
Oklahoma | 1 | 2003 | 36 | 0.010 |
Why?
|
Southwestern United States | 1 | 2003 | 39 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6048 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2932 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.010 |
Why?
|
Body Weight | 2 | 2010 | 4611 | 0.010 |
Why?
|
Thalassemia | 2 | 1995 | 270 | 0.010 |
Why?
|
Sex Factors | 3 | 2008 | 10547 | 0.010 |
Why?
|
Family | 1 | 1994 | 3189 | 0.010 |
Why?
|
Skin Tests | 2 | 1995 | 637 | 0.010 |
Why?
|
Medical History Taking | 1 | 2006 | 773 | 0.010 |
Why?
|
Sample Size | 1 | 2006 | 840 | 0.010 |
Why?
|
Smoking | 2 | 1998 | 9073 | 0.010 |
Why?
|
Smoke | 1 | 2003 | 236 | 0.010 |
Why?
|
Belgium | 1 | 2001 | 118 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2180 | 0.010 |
Why?
|
Selection Bias | 1 | 2003 | 358 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2012 | 2781 | 0.010 |
Why?
|
Eye Diseases | 1 | 1987 | 651 | 0.010 |
Why?
|
Air Pollution | 1 | 1995 | 2317 | 0.010 |
Why?
|
Menopause | 1 | 1989 | 1640 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 2000 | 40 | 0.010 |
Why?
|
New Zealand | 1 | 2001 | 355 | 0.010 |
Why?
|
Cues | 1 | 1986 | 867 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2005 | 749 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4291 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1992 | 3562 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2061 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 2 | 1997 | 2569 | 0.010 |
Why?
|
Risk | 2 | 1995 | 9631 | 0.010 |
Why?
|
Birth Weight | 2 | 2001 | 2097 | 0.010 |
Why?
|
Hemoglobins | 2 | 1998 | 1521 | 0.010 |
Why?
|
New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
Raphe Nuclei | 1 | 2000 | 103 | 0.010 |
Why?
|
Indians, North American | 1 | 2003 | 350 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2672 | 0.010 |
Why?
|
Cephalometry | 1 | 2001 | 382 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5508 | 0.010 |
Why?
|
Reaction Time | 1 | 1986 | 2075 | 0.010 |
Why?
|
Fever | 1 | 2007 | 1617 | 0.010 |
Why?
|
Visual Fields | 1 | 1986 | 1054 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2007 | 1276 | 0.010 |
Why?
|
Leukocytosis | 1 | 2000 | 251 | 0.010 |
Why?
|
Tritium | 1 | 1998 | 707 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7806 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4433 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3455 | 0.010 |
Why?
|
Brazil | 1 | 2001 | 1218 | 0.010 |
Why?
|
Ethanol | 1 | 2003 | 1323 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 1998 | 138 | 0.010 |
Why?
|
Insurance, Health | 1 | 2009 | 2501 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.010 |
Why?
|
Genomics | 1 | 2013 | 5794 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2282 | 0.010 |
Why?
|
Age Determination by Skeleton | 1 | 1997 | 126 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2000 | 651 | 0.010 |
Why?
|
Fallopian Tube Diseases | 1 | 1997 | 60 | 0.010 |
Why?
|
Hysteroscopy | 1 | 1997 | 67 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20509 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5961 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3527 | 0.010 |
Why?
|
Medicaid | 1 | 2009 | 2815 | 0.010 |
Why?
|
Uterine Diseases | 1 | 1997 | 117 | 0.010 |
Why?
|
beta Carotene | 1 | 1997 | 524 | 0.010 |
Why?
|
Hemarthrosis | 1 | 1995 | 39 | 0.010 |
Why?
|
Animals | 3 | 2021 | 167963 | 0.010 |
Why?
|
Swine | 1 | 2005 | 5899 | 0.010 |
Why?
|
Life Tables | 1 | 1995 | 365 | 0.010 |
Why?
|
Respiratory System | 1 | 1998 | 557 | 0.010 |
Why?
|
Naloxone | 1 | 1998 | 369 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2005 | 2733 | 0.010 |
Why?
|
Heart | 1 | 2008 | 4393 | 0.010 |
Why?
|
Testosterone | 2 | 1997 | 2470 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 1995 | 85 | 0.010 |
Why?
|
Splenic Diseases | 1 | 1995 | 90 | 0.010 |
Why?
|
Videotape Recording | 1 | 1996 | 337 | 0.010 |
Why?
|
Aspirin | 1 | 2007 | 3364 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 1995 | 490 | 0.010 |
Why?
|
Apgar Score | 1 | 1994 | 126 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6771 | 0.010 |
Why?
|
Jaundice, Neonatal | 1 | 1994 | 71 | 0.010 |
Why?
|
Extremities | 1 | 2000 | 867 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2011 | 4775 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 1994 | 157 | 0.010 |
Why?
|
Sperm Count | 1 | 1995 | 228 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1994 | 346 | 0.010 |
Why?
|
Erythrocytes, Abnormal | 1 | 1994 | 121 | 0.010 |
Why?
|
Mathematics | 1 | 1995 | 707 | 0.010 |
Why?
|
Erythrocyte Indices | 1 | 1994 | 145 | 0.010 |
Why?
|
Meningitis | 1 | 1995 | 218 | 0.010 |
Why?
|
Sperm Motility | 1 | 1995 | 265 | 0.010 |
Why?
|
Myocardium | 1 | 2006 | 4700 | 0.010 |
Why?
|
Reticulocytes | 1 | 1994 | 288 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2262 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2418 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1992 | 21025 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1998 | 1015 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1994 | 310 | 0.010 |
Why?
|
Nicotine | 1 | 1998 | 677 | 0.010 |
Why?
|
Arousal | 1 | 1998 | 1157 | 0.010 |
Why?
|
Skull | 1 | 1997 | 815 | 0.010 |
Why?
|
Pain | 2 | 2000 | 5066 | 0.010 |
Why?
|
Sexual Maturation | 1 | 1994 | 260 | 0.010 |
Why?
|
Bilirubin | 1 | 1994 | 438 | 0.010 |
Why?
|
Anesthesia, Conduction | 1 | 1995 | 261 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1998 | 901 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1995 | 979 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1994 | 342 | 0.010 |
Why?
|
Platelet Count | 1 | 1994 | 777 | 0.010 |
Why?
|
Hemoglobin, Sickle | 1 | 1991 | 113 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4925 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2003 | 2496 | 0.010 |
Why?
|
Population Surveillance | 1 | 2001 | 2608 | 0.010 |
Why?
|
Respiratory Sounds | 1 | 1995 | 697 | 0.010 |
Why?
|
Education | 1 | 1994 | 534 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1994 | 859 | 0.010 |
Why?
|
Chest Pain | 1 | 1998 | 1106 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1995 | 566 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1997 | 1168 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1994 | 1600 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1995 | 596 | 0.010 |
Why?
|
Anemia | 1 | 2000 | 1511 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1995 | 1557 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1997 | 1928 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 1996 | 1405 | 0.000 |
Why?
|
Anesthesia, General | 1 | 1995 | 1166 | 0.000 |
Why?
|
Antigens | 1 | 1994 | 1447 | 0.000 |
Why?
|
Affect | 1 | 1996 | 1480 | 0.000 |
Why?
|
Disease Susceptibility | 1 | 1995 | 1791 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1989 | 11712 | 0.000 |
Why?
|
Recurrence | 1 | 2000 | 8482 | 0.000 |
Why?
|
Program Evaluation | 1 | 1996 | 2493 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15757 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8651 | 0.000 |
Why?
|
Range of Motion, Articular | 1 | 1993 | 1583 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2006 | 7818 | 0.000 |
Why?
|
Lymphocytes | 1 | 1994 | 2611 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2005 | 18137 | 0.000 |
Why?
|
Patient Compliance | 1 | 1996 | 2688 | 0.000 |
Why?
|
Vaccines | 1 | 1994 | 832 | 0.000 |
Why?
|
Schools | 1 | 1994 | 1480 | 0.000 |
Why?
|
Lung Diseases | 1 | 1995 | 1915 | 0.000 |
Why?
|
Patient Admission | 1 | 1992 | 1386 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 2394 | 0.000 |
Why?
|
Tamoxifen | 1 | 1989 | 963 | 0.000 |
Why?
|
Laparoscopy | 1 | 1997 | 2147 | 0.000 |
Why?
|
Prednisone | 1 | 1989 | 1565 | 0.000 |
Why?
|
Fluorouracil | 1 | 1989 | 1631 | 0.000 |
Why?
|
Hypertension | 1 | 2004 | 8594 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1989 | 2221 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1995 | 4353 | 0.000 |
Why?
|
Methotrexate | 1 | 1989 | 1719 | 0.000 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1995 | 4550 | 0.000 |
Why?
|
Radiography | 1 | 1993 | 6965 | 0.000 |
Why?
|
Mental Health | 1 | 1996 | 3213 | 0.000 |
Why?
|
Rats | 1 | 1998 | 23711 | 0.000 |
Why?
|
Receptors, Estrogen | 1 | 1989 | 2210 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 1994 | 2942 | 0.000 |
Why?
|
Inflammation | 1 | 2000 | 10756 | 0.000 |
Why?
|
Massachusetts | 1 | 1992 | 8803 | 0.000 |
Why?
|